Ultragenyx Pharmaceutical Inc. (RARE) Dipped -8.11% or -6.45 To Price $73.13 On Friday


Ultragenyx Pharmaceutical Inc. (RARE) dipped -8.11% or -6.45 to $73.13. It is around 682233 shares traded, which is 147.86% compare to the average total volume 461402. The market cap of RARE is $3.64 billion. The year to date change is 53.35%. The 52 week price range is from $41.67 to $87.33. Price of RARE have changed 2.38% during last week. It have changed 1.62% over last month, 51.84% over last 3 months, 55.22% over last 6 months and 25.64% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RARE is 78.60. It is 7.48% above current price. The 200-day Moving Averages for RARE is 57.71. It is -21.09% below current price. The 52-week High is 87.33. It is 19.42% from the current price. The 52-week Low is 41.67. It is -43.02% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RARE is 8.93 on 2018-07-13. Short % to float is 10.16%. There are some statistics of RARE. It is has market cap $3.64 billion. The share outstanding is 49.77 million. The average volume is 461402. The revenue is 2.61M. The gross profit is 2.41M. The percent of top 15 Institution holding is 99.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RARE is -31.59%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RARE is -28.10%.


Tags:

Share this post